Does NINTEDANIB Cause Injection site extravasation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Injection site extravasation have been filed in association with NINTEDANIB. This represents 0.0% of all adverse event reports for NINTEDANIB.
9
Reports of Injection site extravasation with NINTEDANIB
0.0%
of all NINTEDANIB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Injection site extravasation From NINTEDANIB?
Of the 9 reports, 9 (100.0%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does NINTEDANIB Cause?
Diarrhoea (9,103)
Nausea (4,198)
Dyspnoea (3,080)
Decreased appetite (2,832)
Death (2,790)
Weight decreased (2,628)
Vomiting (2,524)
Fatigue (2,511)
Cough (2,193)
Idiopathic pulmonary fibrosis (1,905)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which NINTEDANIB Alternatives Have Lower Injection site extravasation Risk?
NINTEDANIB vs NINTEDANIB ESYLATE
NINTEDANIB vs NIRAPARIB
NINTEDANIB vs NIRMATRELVIR\RITONAVIR
NINTEDANIB vs NIROGACESTAT
NINTEDANIB vs NIROGACESTAT HYDROBROMIDE